Gelomics is an Australian company founded in 2018. Our mission is to provide the research community with the highest quality 3D cell culture technology at affordable prices. Our products are manufactured to industrial standards using validated protocols and enable reproducible studies with outstanding predictive value.
Dr Christoph Meinert
Dr Christoph Meinert completed his PhD in Bioengineering from the Queensland University of Technology in 2017. In addition to his expertise in hydrogel cultures that span many different cell types, Christoph has led the development of key technologies that enable 3D cell culture.
A/Prof Travis Klein earned his PhD in bioengineering from the University of California, San Diego (UCSD) in 2005. His hydrogel experience goes back to the early days of his PhD, with alginate, and he has continued working with a range of hydrogels since then with his students and post-doctoral researchers.
Dietmar W. Hutmacher
D/Prof Dietmar W. Hutmacher is a biomedical engineer, educator, inventor, and creator of new intellectual property and entrepreneurial opportunities. He is a global leader in biomaterial science, biomedical and tissue engineering and regenerative medicine. D/Prof Hutmacher is one of few academics who translated a tissue engineering concept from bench to bedside.